Services Catalog » DAR ratio (drug-antibody ratio) by LC-MS
Services
DAR ratio (drug-antibody ratio) by LC-MS
Characterization of a drug or comparability studies
Therapeutic Modalities:
Biologics
Development Phases:
Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial
Quality Standard:
GMP and non-GMP (ISO 9001:2015)
